Malignant melanoma is the most lethal form of skin cancer that can develop in several forms from melanocytes in the epidermis and dermis. Risk factors include fair skin, red/blond hair, family history, and sun exposure. Symptoms vary depending on the type but may appear as irregular colored lesions. Diagnosis involves biopsy and staging tests. Treatment options depend on invasion depth and may include surgery, chemotherapy, and immunotherapy. Nursing focuses on managing pain, reducing anxiety, educating on symptoms of metastasis, and supporting the patient.
Cancer is a life-threatening disease. 80% to 90% of all cancers are the result of the things we do to ourselves. Among women, breast cancer is the second most common cancer.
cancer of breast , this slide cointains detailed information about the breast cancer that is definition, causes and risk factor, sign and symptoms, management of patient with cancer , giving psychological support .treatment
An acute or chronic disease in humans and other warm-blooded animals characterized by an abnormal increase in the number of white blood cells in the tissues and often in the blood.
Cancer of liver usually results from metastasis from a primary cancer at a distant location.
The liver is likely area of involvement i.e. cancer originated in the esophagus, lungs ,breast, stomach, colon, pancreas, kidney, bladder etc.Hepatic tumor may be malignant or benign.
Cancer is a life-threatening disease. 80% to 90% of all cancers are the result of the things we do to ourselves. Among women, breast cancer is the second most common cancer.
cancer of breast , this slide cointains detailed information about the breast cancer that is definition, causes and risk factor, sign and symptoms, management of patient with cancer , giving psychological support .treatment
An acute or chronic disease in humans and other warm-blooded animals characterized by an abnormal increase in the number of white blood cells in the tissues and often in the blood.
Cancer of liver usually results from metastasis from a primary cancer at a distant location.
The liver is likely area of involvement i.e. cancer originated in the esophagus, lungs ,breast, stomach, colon, pancreas, kidney, bladder etc.Hepatic tumor may be malignant or benign.
power point presentation on the various pigmented lesions in the oral mucosa with their clinical features and oral manifestations and differential diagnosis
Please find the power point (ppt.) on everything that you need to know about Malignant melanoma in very simple language by Sunil kumar Daha from very reliable references. Especially focused on surgical interventions. Thank you
Dr. Ana Ciurea presents the basics of melanoma preventio, screening and diagnosis at the MRF's Patient Symposium at MD Anderson Cancer Center on January 31, 2015.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
2. A malignant melanoma is a malignant
neoplasm in which atypical melanocytes
(pigment cells) are present in both the
epidermis and the dermis (and sometimes
the subcutaneous cells).
It is the most lethal of all skin cancers. It can
occur in one of several forms: superficial
spreading melanoma, lentigomaligna
melanoma, nodular melanoma, and acral-
lentiginous melanoma.
3. Most melanomas are derived from
cutaneous epidermal melanocytes; some
appear in preexisting nevi (moles) in the
skin or develop in the uveal tract of the
eye. Melanomas occasionally appear
simultaneously with cancer of other
organs.
4. Malignant melanoma can spread through
both the bloodstream and lymphatic
system and can metastasize to the bones,
liver, lungs, spleen, CNS, and lymph
nodes.
5. RISK FACTORSThe cause of malignant melanoma is unknown, but
ultraviolet rays are strongly suspected. Risk
factors include the following:
– Fair complexion, blue eyes, red or blond hair, and
freckles
– Celtic or Scandinavian origin
– Tendency to burn and not tan; significant history of
severe sunburn
– Older age; residence in the southwestern United
States
– Family or personal history of melanoma, the absence
of a gene on chromosome 9P, presence of giant
congenital nevi
– Dysplastic nevus syndrome
6. CLINICAL MANIFESTATIONS
A. Superficial Spreading Melanoma
Most common form; usually affects
middle-aged people, occurs most
frequently on trunk and lower
extremities
–Circular lesions with irregular outer
portions
–Margins of lesion flat or elevated and
palpable
–May appear in combination of colors,
with hues of tan, brown, and black
mixed with gray, bluish black, or white;
7. B. Lentigo-Maligna Melanoma
–Slowly evolving pigmented lesion
–Occurs on exposed skin areas; hand,
head, and neck in elderly people
–First appears as tan, flat lesion, which in
time undergoes changes in size and
color
8. C. Nodular Melanoma
–Spherical, blueberry-like nodule with
relatively smooth surface and uniform
blue-black color
–May be dome-shaped with a smooth
surface or have other shadings of red,
gray, or purple
–May appear as irregularly shaped
plaques
–May be described as a blood blister that
fails to resolve
–Invades directly into adjacent dermis
(vertical growth); poor prognosis
9. D. Acral-Lentiginous Melanoma
–Occurs in areas not excessively
exposed to sunlight and where hair
follicles are absent
–Found on the palms of the hands, soles,
in nail beds, and mucous membranes in
dark-skinned people
–Appears as an irregular pigmented
macule that develops nodules
–Becomes invasive early
10. ASSESSMENT AND
DIAGNOSTIC METHODS
• Excisional biopsy specimen; incisional
biopsy when the suspicious lesion is too
large to be removed safely without
extensive scarring.
• Chest x-ray, complete blood cell count,
liver function tests, and radionuclide or CT
scans are ordered for staging once
melanoma is confirmed.
11. MEDICAL MANAGEMENT
The therapeutic approach to malignant
melanoma depends on the level of
invasion and the depth of the lesion.
In addition to surgery, chemotherapy and
induced hyperthermia may be used to
enhance treatment. Investigators are
exploring the potential for the use of lipid-
lowering medications and vaccine therapy
to prevent melanoma
12. Surgical Management
• Surgical excision is the treatment of
choice for small superficial lesions.
• Deeper lesions require wide local
excision and skin graft.
• A regional lymph node dissection may
be performed to rule out metastasis,
although newer approaches call for
sentinel node biopsy to avoid problems
from extensive lymph node removal.
• Debulking the tumor or other palliative
procedures may be performed.
13. PLANNING AND GOALS
The major goals for the patient may
include relief of pain and discomfort,
reduced anxiety and depression,
increased knowledge of early signs of
melanoma, and absence of
complications.
14. NURSING INTERVENTIONS
• Relieving Pain and Discomfort
– Promote comfort and anticipate need for and
administer appropriate analgesic agents.
• Reducing Anxiety
– Give support, and allow patient to express
feelings (eg, anxiety, depression).
– Convey understanding of feelings.
15. –Answer questions and clarify information
during the diagnostic workup and
staging of the tumor.
–Point out resources, past effective
coping mechanisms, and support
systems to help the patient cope with
diagnosis and treatment.
–Include immediate family in all
discussions to clarify information and
provide emotional support.
16. MONITORING AND MANAGING
POTENTIAL COMPLICATIONS
Metastasis
• Educate patient about treatment and
deliver supportive care, provide and clarify
information about the therapy and the
rationale for its use, identify potential side
effects of therapy and ways to manage
them, and instruct the patient and family
about the expected outcomes of
treatment.
17. • Monitor and document symptoms that may
indicate metastasis: lung (eg, difficulty
breathing, shortness of breath, increasing
cough), bone (eg, pain, decreased mobility
and function, pathologic fractures), and
liver (eg, change in liver enzyme levels,
pain, jaundice).
18. • Encourage patient to have hope in the
therapy while being realistic.
• Provide time for patient to express fears
and concerns about the future.
• Offer information about support groups
and contact people.
• Arrange for hospice and palliative care
services.